Semin Thromb Hemost 2019; 45(05): 544-547
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Vascular Disease and Dementia: Lipoprotein(a) as a Neglected Link
Giuseppe Lippi
1
Section of Clinical Biochemistry, University of Verona, Verona, Italy
,
Elisa Danese
1
Section of Clinical Biochemistry, University of Verona, Verona, Italy
,
Emmanuel J. Favaloro
2
Department of Haematology, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead Hospital, Westmead, New South Wales, Australia
› Author Affiliations
References
1
de Mello Gomide Loures C,
Figueiredo Duarte RC,
Ferreira Silva MV.
, et al. Hemostatic abnormalities in dementia: a systematic review and meta-analysis. Semin Thromb Hemost 2019; 45 (05) 514-522
2
Montagnana M,
Lippi G,
Danese E.
An overview of thrombophilia and associated laboratory testing. Methods Mol Biol 2017; 1646: 113-135
3
Lippi G,
Guidi G.
Lipoprotein(a): from ancestral benefit to modern pathogen?. QJM 2000; 93 (02) 75-84
4
Lippi G,
Franchini M,
Salvagno GL,
Guidi GC.
Lipoprotein[a] and cancer: anti-neoplastic effect besides its cardiovascular potency. Cancer Treat Rev 2007; 33 (05) 427-436
5
Urakami K,
Mura T,
Takahashi K.
Lp(a) lipoprotein in cerebrovascular disease and dementia. Jpn J Psychiatry Neurol 1987; 41 (04) 743-748
6
Kuriyama M,
Hokezu Y,
Togo S.
, et al. Serum lipids, lipoproteins and apolipoproteins in patients with senile dementia [in Japanese]. Nippon Ronen Igakkai Zasshi 1992; 29 (7-8): 559-564
7
Caramelli P,
Nitrini R,
Maranhão R.
, et al. Increased apolipoprotein B serum concentration in Alzheimer's disease. Acta Neurol Scand 1999; 100 (01) 61-63
8
Urakami K,
Wada-Isoe K,
Wakutani Y.
, et al. Lipoprotein(a) phenotypes in patients with vascular dementia. Dement Geriatr Cogn Disord 2000; 11 (03) 135-138
9
Mooser V,
Helbecque N,
Miklossy J,
Marcovina SM,
Nicod P,
Amouyel P.
Interactions between apolipoprotein E and apolipoprotein(a) in patients with late-onset Alzheimer disease. Ann Intern Med 2000; 132 (07) 533-537
10
Zuliani G,
Ble' A,
Zanca R.
, et al. Lipoprotein profile in older patients with vascular dementia and Alzheimer's disease. BMC Geriatr 2001; 1: 5
11
Solfrizzi V,
Panza F,
D'Introno A.
, et al. Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 72 (06) 732-736
12
Emanuele E,
Peros E,
Tomaino C.
, et al. Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans. Neurosci Lett 2003; 353 (03) 201-204
13
Emanuele E,
Peros E,
Tomaino C.
, et al. Relation of apolipoprotein(a) size to Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 2004; 18 (02) 189-196
14
Emanuele E,
Peros E,
Tomaino C.
, et al. Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease. Neurosci Lett 2004; 357 (01) 45-48
15
Iwamoto T,
Watanabe D,
Umahara T.
, et al. Dual inverse effects of lipoprotein(a) on the dementia process in Japanese late-onset Alzheimer's disease. Psychogeriatrics 2004; 4 (06) 64-71
16
Watanabe T,
Koba S,
Kawamura M.
, et al. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia. Metabolism 2004; 53 (04) 476-482
17
Pantoni L,
Sarti C,
Pescini F.
, et al. Thrombophilic risk factors and unusual clinical features in three Italian CADASIL patients. Eur J Neurol 2004; 11 (11) 782-787
18
Cankurtaran M,
Yavuz BB,
Halil M,
Dagli N,
Cankurtaran ES,
Ariogul S.
Are serum lipid and lipoprotein levels related to dementia?. Arch Gerontol Geriatr 2005; 41 (01) 31-39
19
Ban Y,
Watanabe T,
Suguro T.
, et al. Increased plasma urotensin-II and carotid atherosclerosis are associated with vascular dementia. J Atheroscler Thromb 2009; 16 (03) 179-187
20
Gong M,
Rueschendorf F,
Marx P.
, et al. Clinical and genetic features in a family with CADASIL and high lipoprotein (a) values. J Neurol 2010; 257 (08) 1240-1245
21
Valenti R,
Nannucci S,
Pescini F,
Bianchi S,
Inzitari D,
Pantoni L.
High lipoprotein(a) serum levels in three CADASIL families. J Neurol 2012; 259 (02) 379-380
22
Ray L,
Khemka VK,
Behera P.
, et al. Serum homocysteine, dehydroepiandrosterone sulphate and lipoprotein (a) in Alzheimer's disease and vascular dementia. Aging Dis 2013; 4 (02) 57-64
23
Kunutsor SK,
Khan H,
Nyyssönen K,
Laukkanen JA.
Is lipoprotein (a) protective of dementia?. Eur J Epidemiol 2016; 31 (11) 1149-1152
24
Sarti C,
Pantoni L,
Pracucci G,
Di Carlo A,
Vanni P,
Inzitari D.
; Italian Longitudinal Study on Aging (ILSA). Lipoprotein(a) and cognitive performances in an elderly white population: cross-sectional and follow-up data. Stroke 2001; 32 (07) 1678-1683
25
Iemolo F,
Duro G,
Rizzo C,
Castiglia L,
Hachinski V,
Caruso C.
Pathophysiology of vascular dementia. Immun Ageing 2009; 6: 13
26
Kotani K,
Serban MC,
Penson P,
Lippi G,
Banach M.
Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases - Some answers and still many questions. Crit Rev Clin Lab Sci 2016; 53 (06) 370-378
27
Riches K,
Porter KE.
Lipoprotein(a): cellular effects and molecular mechanisms. Cholesterol 2012; 2012: 923289
28
Zuliani G,
Cavalieri M,
Galvani M.
, et al. Markers of endothelial dysfunction in older subjects with late onset Alzheimer's disease or vascular dementia. J Neurol Sci 2008; 272 (1-2): 164-170
29
Dentali F,
Gessi V,
Marcucci R,
Gianni M,
Grandi AM,
Franchini M.
Lipoprotein(a) as a risk factor for venous thromboembolism: a systematic review and meta-analysis of the literature. Semin Thromb Hemost 2017; 43 (06) 614-620
30
Anglés-Cano E,
de la Peña Díaz A,
Loyau S.
Inhibition of fibrinolysis by lipoprotein(a). Ann N Y Acad Sci 2001; 936: 261-275
31
Sevush S,
Jy W,
Horstman LL,
Mao WW,
Kolodny L,
Ahn YS.
Platelet activation in Alzheimer disease. Arch Neurol 1998; 55 (04) 530-536
32
Takechi R,
Galloway S,
Pallebage-Gamarallage M,
Wellington C,
Johnsen R,
Mamo JC.
Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice. Histochem Cell Biol 2009; 131 (05) 661-666
33
Leung YY,
Toledo JB,
Nefedov A.
, et al. Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study. Alzheimers Dement (Amst) 2015; 1 (03) 339-348
34
Lippi G,
Targher G,
Salvagno GL,
Montagnana M,
Franchini M,
Guidi GC.
Lipoprotein(a) and ageing. Clin Lab 2010; 56 (9-10): 463-466
